Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Briacell Therapeutics Corp BCTXW


Primary Symbol: T.BCT Alternate Symbol(s):  BCTX

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted... see more

TSX:BCT - Post Discussion

Briacell Therapeutics Corp > What does "Pre-funded" mean? Not a "nominal price"?
View:
Post by MineDigger on Mar 15, 2021 2:41pm

What does "Pre-funded" mean? Not a "nominal price"?

Hi, grateful if someone could explain this "pre-funded" lark.

I read, this pdf link, that "pre-funded" warrants have a "nominal" strike price (just a cent normally), but I'm seeing IB showing me the BCTXW strike is U$5.3125.

I see (same pdf) there is an explanation of how pre-funded warrants can be used to avoid exceesing ownership thresholds. Is that what is necessary here does anyone know?

And once that is explained if someone could show me how the offering price is made up (by way of a worked eample hopefully)?

I've held some of these since 2015 and despite averaging down seem to have a b/e price of something that is going to require some impressive clinical results now! That HLA matching seemed to a good idea, should I still be hopeful?

Cheers

MD
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities